Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION, USP

Last updated on 2019-09-11 History
Report ID 78454
Drug Identification Number 02387468
Brand name LABETALOL HYDROCHLORIDE INJECTION, USP
Common or Proper name LABETALOL HYDROCHLORIDE INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC
Active Ingredient(s) LABETALOL HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20ML 1VL
ATC code C07AG
ATC description BETA BLOCKING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-09-10
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-09-11
Company comments ID 10718 was resolved in error on Mar-8-2019. Reopened in this ID.
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-03-13 English Compare
v2 2019-03-13 French Compare
v3 2019-04-10 English Compare
v4 2019-04-30 English Compare
v5 2019-04-30 French Compare
v6 2019-05-02 English Compare
v7 2019-05-08 English Compare
v8 2019-05-08 French Compare
v9 2019-05-09 English Compare
v10 2019-05-14 English Compare
v11 2019-05-14 French Compare
v12 2019-05-16 English Compare
v13 2019-05-22 English Compare
v14 2019-05-22 French Compare
v15 2019-05-23 English Compare
v16 2019-05-28 English Compare
v17 2019-05-28 French Compare
v18 2019-05-28 English Compare
v19 2019-05-28 French Compare
v20 2019-05-30 English Compare

Showing 1 to 20 of 58